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Similarities of Akt Activation in Cutaneous Wound Repair and Skin Carcinogenesis
Nesrine I. Affara1, Brandon L. Schanbacher2, Ping Pei3, Susan R. Mallery3, Carol S. Trempus4,
John A. Bauer2 and Fredika M. Robertson1
1Department of Molecular Virology, Immunology & Medical Genetics, The Ohio State University,
Columbus, Ohio, USA; 2The Center for Cardiovascular Pharmacology, Columbus Children’s
Research Institute, Columbus, Ohio, USA; 3Department of Oral Maxillofacial Surgery, Oral
Pathology and Periodontology, The Ohio State University, Columbus, Ohio, USA and 4National
Center for Toxicogenomics, National Institute of Environmental Health Sciences, Research
Triangle Park, North Carolina, USA
The putative CD34þ /K15þ stem cells of the skin, which have been identified specifically within
the ‘‘bulge region’’ of hair follicles, have recently been shown to be able to reconstitute all
lineages of cells within the epidermis, hair follicles, and sebaceous glands within the skin.
Although these cells are believed to play an important role during the normal regeneration of the
skin and in the wound healing process, there have been no studies to define the location of stem
cells during wound healing, nor have there been any reports identifying the signal-transduction
pathways by which this stem cell population persists in the skin during homeostasis, wound
repair, and development of skin tumors. One signaling molecule shown to be involved in both
survival and proliferation of normal cells as well as tumor cells is Akt-1/protein kinase B.
The goal of the present study was to identify cell populations that contain activated Akt-1, as
determined by the detection of phosphorylation of Akt at serine-473 (pAkt), over the time course
of murine wound repair following full-thickness wounding. These studies used a combination of
digital image analysis, immunohistochemistry, and triple-color immunofluorescence techniques
to locate the stem cell populations within the skin and to quantitate the pAkt during wound
healing.
In normal mouse skin, CD34þ /K15þ stem cells were localized within the bulge region of hair
follicles. At 24 and 48 hours, Akt-1 phosphorylation was present in epidermal keratinocytes
adjacent to the wound site compared to significantly fewer cells containing pAkt at sites proximal
and distal to the wound. At day 5, the majority of epidermal keratinocytes within the wound site
contained pAkt, which was located in both the nuclear and cytosolic regions of each cell. The
cells containing pAkt had the appearance of streaming into the wound bed. At day 9, re-
epithelialization of the wound site was complete, and the majority of epidermal keratinocytes
within the basal and suprabasal regions adjacent to the wound site did not contain pAkt. At this
time point, levels of this signaling molecule were comparable to pAkt in keratinocytes in
unwounded skin.
These observations are the first to characterize the temporal sequence of Akt-1 activation within
specific skin cell populations, including the CD34þ /K15þ stem cells, over the time course of
wound repair and regeneration. Given the ability of Akt to regulate cell survival and proliferation,
the results of the present studies suggest that Akt-1 is a critical event that occurs at early times
during wound repair. The activation of Akt-1 within these specific cell populations may provide
the putative ‘‘stem cells’’ that migrate into the leading edge of the wound with the ability to resist
terminal differentiation and to undergo the necessary proliferation to complete re-epithelializa-
tion of the wound site. These results suggest that Akt-1 may be one pathway by which CD34þ /
K15þ skin stem cells survive during wound healing, thus maintaining their ability to serve as a
self-renewing population of cells during wound repair of the skin. Our observation that Akt-1 is
activated in CD34þ /K15þ stem cell populations during wound repair is similar to our results
demonstrating that Akt-1 activation occurs at early times during the development of pre-
malignant skin papillomas within the CD34þ /K15þ cell population. Taken together, these
results lend support to the hypothesis that the Akt-1 signaling pathway may be common to both
wound repair and skin carcinogenesis.
Nrf Transcription Factors are Crucial for Skin Tumor Prevention but not for
Wound Healing
Ulrich auf dem Keller1, Marcel Huber2, Tobias Beyer1, Philippe Bugnon1, Susanne Braun1,
Thomas Ru¨licke3, Delinda A. Johnson4, Jeffrey A. Johnson4, Daniel Hohl2 and Sabine Werner1
1Department of Biology, Institute of Cell Biology, ETH Zu¨rich, Ho¨nggerberg, Zu¨rich, Switzerland;
2Service de Dermatologie, CHUV Hoˆpital Beaumont, Lausanne, Switzerland; 3Institute of
Laboratory Animal Science, Universita¨t Zu¨rich, Zu¨rich, Switzerland and 4University of
Wisconsin, School of Pharmacy, Madison, Wisconsin, USA
The Nrf2 transcription factor is a key player in the cellular stress response through its regulation of
various cytoprotective genes. In this study, we determined the role of Nrf2-mediated gene
expression in keratinocytes for skin development, wound repair, and skin carcinogenesis. To
overcome a possible compensatory effect exerted by the related Nrf1 and Nrf3 transcription
factors, we chose to express a dominant-negative Nrf2 mutant in the epidermis of transgenic
mice. The functionality of the transgene was proven in vitro and in vivo. Although primary
keratinocytes from these animals revealed an enhanced rate of apoptosis, in particular in response
to oxidative stress, no abnormalities of the epidermis were observed in vivo. Most surprisingly, the
healing process of full-thickness excisional wounds proceeded normally in the transgenic
animals. However, the onset, incidence, and multiplicity of chemically induced skin cancers
were strikingly enhanced. This finding reveals a crucial role of Nrf-mediated gene expression in
the prevention of skin tumors and suggests that activation of Nrf2 in keratinocytes could be
explored to prevent carcinogenesis of this highly exposed organ.
Regulation of Vascular Endothelial Growth Factor-A Protein Activity During
Wound Repair
Detlev Roth1, Michael Piekarek1, Mats Paulsson2,3, Thomas Krieg1,3, Jeffrey M. Davidson4,5 and
Sabine A. Eming1
1Department of Dermatology, University of Cologne, Cologne, Germany; 2Center for
Biochemistry, Medical Faculty, University of Cologne, Cologne, Germany; 3Center for Molecular
Medicine, University of Cologne, Cologne, Germany; 4Department of Pathology, Vanderbilt
University School of Medicine and 5VA Medical Center, Nashville, Tennessee, USA
Vascular endothelial growth factor-A (VEGF-A) is a potent angiogenic mediator in tissue repair.
Whereas VEGF-A levels are regulated through transcriptional control and mRNA stability, VEGF-
A protein activity can be regulated by proteolytic mechanisms and interaction with other
extracellular molecules. We hypothesize that VEGF-A protein activity is impaired in chronic non-
healing wounds and is in part responsible for the reduced and disturbed angiogenic response in
non-healing wounds. We analyzed VEGF-A expression, protein stability, and the presence of the
most potent endogenous VEGF-A inhibitor, the soluble form of the VEGF receptor-1, in non-
healing versus healing human wounds. VEGF-A mRNA expression was highly upregulated in
non-healing wounds. Interestingly, the stability of VEGF165 protein was significantly reduced in
wound fluid obtained from non-healing wounds. Protease inhibitor studies, protein sequencing,
and matrix-associated laser deserption/ionization time-of-flight mass spectrometry of VEGF
cleavage products, as well as a plamin-resistant VEGF165 mutant indicated that plasmin is one of
the serine proteinases critically involved in this degradation process. In addition, soluble form of
the VEGF receptor-1 mRNA expression and protein levels were highly upregulated in non-healing
versus healing wounds. Only in those chronic wounds, which entered a phase of granulation
tissue formation and finally wound closure, wound-healing progression correlated significantly
with a decline in soluble form of the VEGF receptor-1 levels. Our studies provide two novel
mechanisms as how to VEGF-A protein activity might be inhibited in non-healing versus healing
wounds and provide the basis for novel VEGF-based therapies.
Fibroblast Growth Factor Receptor 2-IIIb is a Critical Mediator of Intercellular
Signalling in Development and Disease
Richard Grose1
1Department of Tumour Biology, Cancer Research UK Clinical Centre, Bart’s & The London
School of Medicine & Dentistry, London, UK
Recent data have shown fibroblast growth factor receptor 2-IIIb (Fgfr2b) to be crucial for the
development of the epidermis and hair follicles in the mouse fetus. As Fgfr2b-null mice die at
birth, we have used a Cre-Lox approach to delete Fgfr2b specifically in keratinized epithelia. This
has allowed us to determine the roles played by Fgfr2b in the adult, where previous studies have
implicated it as a key player in tissue repair.
Mice lacking Fgfr2b in the skin survive into adulthood and are fertile, but display striking
abnormalities in the development of their epidermis and epidermal appendages. However, when
challenged by full-thickness wounding, the mice show no significant defect in their capacity for
repair. Fgfr2b has been suggested to play a tumor suppressive role in the urothelium, and here we
present data that show mice lacking Fgfr2b in the epidermis develop epidermal dysplasia with
age, and are exquisitely sensitive to chemically induced skin carcinogenesis. Thus, although other
Fgf receptors may compensate for Fgfr2b during the repair process, there is a continued
requirement for Fgfr2b during postnatal development, where it acts as a key player in epithelial
homeostasis.
142 Journal of Investigative Dermatology Symposium Proceedings (2006), Volume 11 & 2006 The Society for Investigative Dermatology
ABSTRACTS
Overexpression of Smad7 in Keratinocytes Accelerates Cutaneous Wound Healing
Gangwen Han1, Allen G. Li, Philip Owens1 and Xiao-Jing Wang1
1Departments of Otolaryngology, Dermatology, Cell & Developmental Biology, Oregon Health &
Science University, Portland, Oregon, USA
Transforming growth factor b has both positive and negative effects on cutaneous wound healing.
Smad7 acts as a major downstream antagonist of transforming growth factor b signaling in
keratinocytes and its role in wound healing has not been defined. We have established a Smad7
transgenic mouse line using a keratin 5 (K5) promoter (K5.Smad7), which expresses Smad7
transgene at a mild level (B2-fold of the endogenous Smad7 in the skin). These mice did not have
overt skin defects as shown from our previous Smad7 transgenic mice expressing much higher
levels of the Smad7 transgene (EMBO J 2002;21:2580–2590). K5.Smad7 mice from the above low
expressor line and non-transgenic littermates were subject to 6 mm full-thickness excisional
wounding. K5.Smad7 mice exhibited early scab rejection, reduced inflammation, and
accelerated re-epithelialization as compared with non-transgenic mice. In order to study stage-
specific effects of Smad7 on wound healing, we generated a transgenic model in which Smad7
transgene expression can be induced in the epidermis and hair follicles (gene-switch-Smad7) by
topical RU486 application. Smad7 induction after excisional wounding reduced inflammatory
responses through the suppression of a variety of inflammatory cytokines/chemokines in gene-
switch-Smad7 mice when compared to control mice. Overexpression of Smad7 exhibited
accelerated re-epithelialization, which likely correlated with increased expression of metallo-
proteinases and elevated extracellular signal-regulated kinases signaling in the leading epidermal
edges in gene-switch-Smad7 wounds compared to control wounds. Prolonged Smad7 induction
after excisional wounding reduced dermal fibrotic response and angiogenesis in the dermis,
resulting in accelerated tissue repair. We conclude that the effects of Smad7 on wound healing
are likely owing to blocking the inhibitory effects of transforming growth factor b on cutaneous
wound healing.
Transforming Growth Factor b1 Overexpression in Mouse Keratinocytes Delays
Cutaneous Wound Healing
Philip Owens1, Allen G. Li1, Gangwen Han1 and Xiao-Jing Wang1
1Deparments of Otolaryngology, Dermatology, Cell & Developmental Biology, Oregon Health &
Science University, Portland, Oregon, USA
Transforming growth factor b1 (TGFb1) is a multipotent secreted cytokine that plays a pivotal role
in wound healing. In the present study, we used a mouse model to examine the effects of TGFb1
on cutaneous wound healing, wherein the latent form of TGFb1 is expressed in basal
keratinocytes of the mouse epidermis, targeted by the keratin 5 promoter (K5.TGFb1). In wild
type mice with 6 mm thickness excisional cutaneous wounds, TGFb1 protein levels were elevated
immediately after wounding, and reached a peak level on day 3 post-wounding, which was 3- to
5-fold higher than that in the non-wounded skin, and sharply declined afterwards. This elevated
expression pattern suggests that only transient TGFb1 overexpression is required for normal
wound healing. In contrast, K5.TGFb1 mice with prolonged TGFb1 transgene expression at the
level equivalent to the above peak level in wild-type mice exhibited a significant delay in healing
of 6 mm full-thickness excisional wounds when compared to wild-type mice. Histological
analysis of wounds revealed delayed re-epithelialization, increased inflammation, and prolonged
granular tissue accumulation in K5.TGFb1 mice. Immunohistochemistry analysis revealed
excessive leukocyte infiltration in transgenic wounds when compared to wild-type wounds.
Accumulation of leukocytes was also accompanied by increased expression of inflammatory
cytokines, chemokines, angiogenic factors, and fibrotic factors. Proliferation at the leading edge
of the migrating keratinocytes was reduced in transgenic skin compared to the non-transgenic
skin, evident by proliferating cell nuclear antigen staining. To assess the direct effect of TGFb1 on
keratinocyte migration, we performed an in vitro migration assay and found that 5.TGFb1
keratinocytes had delayed migration when compared with wild-type cells. Our study suggests that
prolonged TGFb1 expression in keratinocytes delays cutaneous wound healing by excessive
inflammation, coupled to a direct inhibitory effect on keratinocyte proliferation and migration.
The Role of Melatonin on Scarring in an Incisional Model of Dermal Wound
Healing in Rats
K Pugazhenthi1, M Kapoor1, P Young1, A Clarkson1, I Hall1 and I Appleton1
1Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand
The role of melatonin in wound healing has not been established. Therefore, in this study, we
investigated the effect of melatonin on wound healing and scar formation. In addition, we have
characterized the temporal and spatial distribution of melatonin receptors during repair.
Melatonin significantly increased the quality of scarring and the rate of repair. The receptors (MT1
and MT2) were expressed in the epidermis and macrophages on day 1 in both the treated and the
control wounds. Thereafter, the expression decreased post day 3. Melatonin treatment also
significantly (Po0.01) increased arginase activity on day 1 and inducible nitric oxide synthase
activity was significantly decreased on days 1 (Po0.01) and (Po0.01), followed by a significant
increase in inducible nitric oxide synthase activity on day 7. Arginase generates proline, the
building block for collagen synthesis. Melatonin treatment increased arginase activity and thereby
collagen synthesis from day 1. It has been reported that increases in nitric oxide production
prolongs the inflammatory phase of wound healing. Melatonin significantly (Po0.01) decreased
nitric oxide synthase activity, which resulted in improved scarring. We conclude that melatonin
improves scarring and that this effect is, in part, mediated by modulation of the enzymes nitric
oxide synthase and arginase.
b2-Adrenergic Receptor Antagonists are Promotogenic in Keratinocytes: Potential
Therapy for Promoting Wound Re-epithelialization
Christine E. Pullar1 and R. Rivkah Isseroff1
1Department of Dermatology, University of California, Davis School of Medicine, Davis,
California, USA
Keratinocytes play an important role in wound repair by migrating directionally from the wound
edge to re-epithelialize cutaneous wounds. They solely express the b2 sub-type of adrenergic
receptor (b2-AR), as do dermal fibroblasts and melanocytes, and also have the capacity to
synthesize catecholamines (b2-AR agonists), generating an autocrine and paracrine mediator
network in the skin.
Previously, we have reported that b2-AR activation delays the wound repair process by
decreasing ERK phosphorylation and retarding keratinocyte polarization, migration, and
proliferation by protein phosphatase 2A-dependent mechanisms. Striking alterations in
cytoskeletal conformation and morphology were also observed. Finally, we convincingly
demonstrated that b2-AR activation decreased the re-epithelialization of human and murine skin
wounds.
Our work suggests that the b2-AR mediator network in the skin puts the ‘‘brakes’’ on re-
epithelialization delaying barrier recovery. b2-AR antagonists block the b2-AR, preventing
endogenously synthesized catecholamine-mediated b2-AR activation. Here, we demonstrate that
b2-AR antagonists increase extracellular signal-regulated kinase phosphorylation, single-cell
migration, and scratch wound healing. Our preliminary work demonstrates that b2-AR
antagonists could have potential as therapeutic agents to accelerate the wound repair process.
Non-endothelial Effects of Vascular Endothelial Growth Factor: Implications for
Wound Repair
Traci A. Wilgus1 and Luisa A. DiPietro1
1Department of Surgery, Burn & Shock Trauma Institute, Loyola University Medical Center,
Maywood, Illinois, USA
Vascular endothelial growth factor-A (VEGF-A) is best known for stimulating endothelial cells and
promoting angiogenesis, but recent studies indicate that VEGF can also signal through its
receptors in some non-endothelial cell types. Recently, we have discovered that keratinocytes
express vascular endothelial growth factor (VEGFR)-1 and dermal fibroblasts express VEGFR-1
and VEGFR-2. In addition, both cell types proliferate in response to VEGF in vitro, suggesting
VEGF may directly affect both re-epithelialization and restoration of dermal architecture during
wound healing in vivo. To determine the importance of VEGF–VEGFR-1 interactions to
keratinocytes, anti-VEGFR-1-blocking antibodies were applied topically to excisional wounds,
and the effect on wound closure was assessed. VEGFR-1 antibody treatment resulted in a
significant delay in re-epithelialization, which correlated with a reduction in proliferating cell
nuclear antigen-positive keratinocytes at the wound edge. To determine if VEGF might influence
fibroblast responses, the effect of systemic administration of neutralizing anti-VEGF antibodies on
scar tissue formation was examined in incisional wounds. Neutralization of VEGF reduced the
size of the scars by approximately 75% compared to control scars, suggesting that VEGF can
modulate collagen deposition and/or remodeling. Together, these data imply that VEGF does not
simply promote wound angiogenesis, but may also act on non-endothelial cell types to influence
wound re-epithelialization and scar formation.
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P63 Isoform Switching is Required for Induction of IjB Kinase-a and Epidermal
Morphogenesis
Maranke I. Koster1, Antonio Costanzo2, Yuji Sano3, Michael Karin3 and Dennis R. Roop1,4
1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas,
USA; 2Department of Dermatology, University of Rome ‘‘Tor Vergata,’’ Rome, Italy; 3Department
of Pharmacology, University of California, San Diego, California, USA and 4Department of
Dermatology, Baylor College of Medicine, Houston, Texas, USA
During normal epidermal development, a shift in the balance of p63 isoform expression from TA-
to DNp63 isoforms occurs. To determine the biological significance of this switch, we generated
an epidermal-specific inducible DNp63 knockdown mouse model. Interestingly, we found that
DNp63 knockdown epidermis failed to undergo terminal differentiation resulting in epidermal
fragility, demonstrating the critical importance for DNp63 isoforms in epidermal terminal
differentiation. In addition, we found that when commitment to terminal differentiation occurs,
DNp63a directly regulates IkB kinase a (IKKa), a key regulator of epidermal, skeletal, and
craniofacial morphogenesis. Furthermore, using BrdU incorporation assays, we found that in
IKKa/ embryos, cells within the proliferative intermediate layer failed to withdraw from the cell
cycle and mature into spinous cells, demonstrating that IKKa is required for this maturation
process. These data are consistent with our finding that IKKa expression levels peak at E15.5,
when this transition takes place. Taken together, our data demonstrate that p63 isoform switching
is required for the induction of IKKa and epidermal morphogenesis. Furthermore, our finding that
downregulating DNp63 expression in vivo causes skin erosions similar to those found in a subset
of ectodermal dysplasia patients provide novel insights into the molecular basis of ectodermal
dysplasias.
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